JP2017505104A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017505104A5 JP2017505104A5 JP2016520077A JP2016520077A JP2017505104A5 JP 2017505104 A5 JP2017505104 A5 JP 2017505104A5 JP 2016520077 A JP2016520077 A JP 2016520077A JP 2016520077 A JP2016520077 A JP 2016520077A JP 2017505104 A5 JP2017505104 A5 JP 2017505104A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- optionally substituted
- acid nanostructure
- nanostructure
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 108020004707 nucleic acids Proteins 0.000 claims 53
- 102000039446 nucleic acids Human genes 0.000 claims 53
- 150000007523 nucleic acids Chemical class 0.000 claims 53
- 239000002086 nanomaterial Substances 0.000 claims 37
- 239000002088 nanocapsule Substances 0.000 claims 15
- 235000001014 amino acid Nutrition 0.000 claims 13
- 150000001413 amino acids Chemical class 0.000 claims 12
- 229920000642 polymer Polymers 0.000 claims 11
- 229920000768 polyamine Polymers 0.000 claims 10
- 102000053602 DNA Human genes 0.000 claims 6
- 108020004414 DNA Proteins 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 230000000295 complement effect Effects 0.000 claims 5
- 229920001577 copolymer Polymers 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 238000009396 hybridization Methods 0.000 claims 4
- 235000018977 lysine Nutrition 0.000 claims 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 3
- 239000004472 Lysine Substances 0.000 claims 3
- 239000002202 Polyethylene glycol Substances 0.000 claims 3
- 229920002873 Polyethylenimine Polymers 0.000 claims 3
- 125000004450 alkenylene group Chemical group 0.000 claims 3
- 125000000732 arylene group Chemical group 0.000 claims 3
- 125000004452 carbocyclyl group Chemical group 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 125000004404 heteroalkyl group Chemical group 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 3
- 239000013612 plasmid Substances 0.000 claims 3
- 229920001223 polyethylene glycol Polymers 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000005017 substituted alkenyl group Chemical group 0.000 claims 3
- 125000000547 substituted alkyl group Chemical group 0.000 claims 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 125000004419 alkynylene group Chemical group 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 125000002091 cationic group Chemical group 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 125000004474 heteroalkylene group Chemical group 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 125000005647 linker group Chemical group 0.000 claims 2
- 239000011777 magnesium Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 125000004426 substituted alkynyl group Chemical group 0.000 claims 2
- 125000003107 substituted aryl group Chemical group 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 125000004434 sulfur atom Chemical group 0.000 claims 2
- 230000008685 targeting Effects 0.000 claims 2
- 239000003981 vehicle Substances 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 108010039918 Polylysine Proteins 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000000032 diagnostic agent Substances 0.000 claims 1
- 229940039227 diagnostic agent Drugs 0.000 claims 1
- 238000005538 encapsulation Methods 0.000 claims 1
- 125000005549 heteroarylene group Chemical group 0.000 claims 1
- 229920001519 homopolymer Polymers 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- -1 lysine amino acids Chemical class 0.000 claims 1
- 150000002669 lysines Chemical class 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 229920000656 polylysine Polymers 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361901820P | 2013-11-08 | 2013-11-08 | |
| US61/901,820 | 2013-11-08 | ||
| US201462021256P | 2014-07-07 | 2014-07-07 | |
| US201462021257P | 2014-07-07 | 2014-07-07 | |
| US62/021,256 | 2014-07-07 | ||
| US62/021,257 | 2014-07-07 | ||
| PCT/US2014/064659 WO2015070080A2 (en) | 2013-11-08 | 2014-11-07 | Nucleic acid nanostructures for in vivo agent delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019177043A Division JP2020022465A (ja) | 2013-11-08 | 2019-09-27 | インビボにおける薬剤送達のための核酸ナノ構造体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017505104A JP2017505104A (ja) | 2017-02-16 |
| JP2017505104A5 true JP2017505104A5 (cg-RX-API-DMAC7.html) | 2017-12-07 |
Family
ID=53042339
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016520077A Ceased JP2017505104A (ja) | 2013-11-08 | 2014-11-07 | インビボにおける薬剤送達のための核酸ナノ構造体 |
| JP2019177043A Pending JP2020022465A (ja) | 2013-11-08 | 2019-09-27 | インビボにおける薬剤送達のための核酸ナノ構造体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019177043A Pending JP2020022465A (ja) | 2013-11-08 | 2019-09-27 | インビボにおける薬剤送達のための核酸ナノ構造体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20160271268A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3065722A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2017505104A (cg-RX-API-DMAC7.html) |
| CN (1) | CN105705143A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015070080A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA39970A (fr) | 2014-05-14 | 2015-11-19 | Alex Levitzki Man And Holdings Ltd | Vecteurs améliorés a base de polyéthylèneimine polyéthylèneglycol |
| WO2017024239A1 (en) * | 2015-08-06 | 2017-02-09 | City Of Hope | Therapeutic cell internalizing conjugates |
| US20190083522A1 (en) * | 2016-03-10 | 2019-03-21 | President And Fellows Of Harvard College | Biosynthetic modules |
| EP3967651A1 (en) | 2016-03-11 | 2022-03-16 | Children's Medical Center Corporation | Nucleic acid nanoswitch catenanes |
| US11513076B2 (en) * | 2016-06-15 | 2022-11-29 | Ludwig-Maximilians-Universität München | Single molecule detection or quantification using DNA nanotechnology |
| CN115948505B (zh) | 2016-08-02 | 2025-07-25 | 哈佛学院院长及董事 | 交叉协同自组装体 |
| US10738338B2 (en) | 2016-10-18 | 2020-08-11 | The Research Foundation for the State University | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate |
| WO2018124423A1 (ko) * | 2016-12-30 | 2018-07-05 | 주식회사 삼양바이오팜 | 플라스미드 디엔에이 전달용 고분자 나노입자 조성물 및 그의 제조방법 |
| WO2020210468A1 (en) | 2019-04-10 | 2020-10-15 | President And Fellows Of Harvard College | Nucleic acid nanostructures crosslinked with oligolysine |
| JP7272643B2 (ja) * | 2019-05-27 | 2023-05-12 | 国立研究開発法人理化学研究所 | ナノデバイス、フォースセンサ、力の測定方法、および試薬キット |
| WO2020247724A1 (en) * | 2019-06-07 | 2020-12-10 | Dana-Farber Cancer Institute, Inc. | Dna nanostructure-based vaccines |
| CN111172146B (zh) * | 2020-01-15 | 2023-09-12 | 苏州朴衡科技有限公司 | 纳米级人工抗原呈递细胞αCD3-Origami aAPC及其制备方法和应用 |
| US20210380988A1 (en) * | 2020-05-13 | 2021-12-09 | University Of Massachusetts | Reducing Prominin2-Mediated Resistance to Ferroptotic Cell Death |
| EP4019633A1 (en) | 2020-12-23 | 2022-06-29 | Technische Universität München | Conditional cell connectors |
| EP4216220A1 (en) * | 2022-01-25 | 2023-07-26 | Leica Microsystems CMS GmbH | Data storage device and method for storing data |
| WO2024044663A2 (en) * | 2022-08-25 | 2024-02-29 | Ohio State Innovation Foundation | Peptide and nucleic acid methods to modulate delivery of nucleic acid structures, polypeptides, and their cargoes |
| WO2024259439A1 (en) * | 2023-06-16 | 2024-12-19 | University Of Connecticut | Nucleic acid nanocapsules for drug delivery |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4267233B2 (ja) * | 1999-09-10 | 2009-05-27 | ジェロン・コーポレーション | オリゴヌクレオチドｎ３’→ｐ５’チオホスホルアミデート：それらの合成および使用 |
| PL358811A1 (en) * | 1999-11-13 | 2004-08-23 | Merck Patent Gmbh | High order nucleic acid based structures |
| JP2002114797A (ja) * | 2000-10-10 | 2002-04-16 | Atsushi Maruyama | 三重鎖核酸を形成するための調製物 |
| CA2570108A1 (en) * | 2004-06-10 | 2006-08-17 | New York University | Polygonal nanostructures of polynucleic acid multi-crossover molecules and assembly of lattices based on double crossover cohesion |
| US20060105049A1 (en) * | 2004-11-12 | 2006-05-18 | Valorisation Recherche Hscm & Universite De Montreal | Folic acid-chitosan-DNA nanoparticles |
| US7964571B2 (en) * | 2004-12-09 | 2011-06-21 | Egen, Inc. | Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases |
| CA2670801A1 (en) * | 2005-11-30 | 2007-06-07 | Intradigm Corporation | Compositions and methods of using sirna to knockdown gene expression and to improve solid organ and cell transplantation |
| US8440229B2 (en) * | 2007-08-14 | 2013-05-14 | The Regents Of The University Of California | Hollow silica nanospheres and methods of making same |
| JP2009213390A (ja) * | 2008-03-10 | 2009-09-24 | Nissan Motor Co Ltd | 核酸複合体 |
| WO2010040091A1 (en) * | 2008-10-03 | 2010-04-08 | Arizona Board of Regents, a body corporate acting for and on behalf of Arizona State University | Novel dna nanostructures that promote cell-cell interaction and use thereof |
| JP5814793B2 (ja) * | 2008-11-25 | 2015-11-17 | エコール ポリテクニク フェデラル ド ローザンヌ（エーペーエフエル） | ブロックコポリマーおよびその使用 |
| EP2275085A1 (en) * | 2009-07-07 | 2011-01-19 | University of Rostock | Biodegradable copolymer suitable for delivering nucleic acid materials into cells |
| EP2766485B1 (en) * | 2011-10-12 | 2020-07-08 | National Centre for Biological Sciences | A nucleic acid assembly, vector, cell, methods and kit thereof |
| WO2013113325A1 (en) * | 2012-01-31 | 2013-08-08 | Curevac Gmbh | Negatively charged nucleic acid comprising complexes for immunostimulation |
| EP2830991A1 (en) * | 2012-03-26 | 2015-02-04 | President and Fellows of Harvard College | Lipid-coated nucleic acid nanostructures of defined shape |
-
2014
- 2014-11-07 CN CN201480061059.XA patent/CN105705143A/zh active Pending
- 2014-11-07 US US15/034,566 patent/US20160271268A1/en not_active Abandoned
- 2014-11-07 EP EP14860290.7A patent/EP3065722A4/en not_active Withdrawn
- 2014-11-07 WO PCT/US2014/064659 patent/WO2015070080A2/en not_active Ceased
- 2014-11-07 JP JP2016520077A patent/JP2017505104A/ja not_active Ceased
-
2019
- 2019-09-27 JP JP2019177043A patent/JP2020022465A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017505104A5 (cg-RX-API-DMAC7.html) | ||
| AU2021203336C1 (en) | Improved polyethyleneimine polyethyleneglycol vectors | |
| Alavi et al. | Hyperbranched–dendrimer architectural copolymer gene delivery using hyperbranched PEI conjugated to poly (propyleneimine) dendrimers: synthesis, characterization, and evaluation of transfection efficiency | |
| Zhou et al. | Ultra-small graphene oxide functionalized with polyethylenimine (PEI) for very efficient gene delivery in cell and zebrafish embryos | |
| Byrne et al. | Molecular weight and architectural dependence of well-defined star-shaped poly (lysine) as a gene delivery vector | |
| Taghavi et al. | Preparation and evaluation of polyethylenimine-functionalized carbon nanotubes tagged with 5TR1 aptamer for targeted delivery of Bcl-xL shRNA into breast cancer cells | |
| US10030103B2 (en) | Stable helical ionic polypeptides | |
| Bono et al. | Role of generation on successful DNA delivery of PAMAM–(Guanidino) Neomycin conjugates | |
| JP2013510181A5 (cg-RX-API-DMAC7.html) | ||
| JP2014505685A5 (cg-RX-API-DMAC7.html) | ||
| US8697667B2 (en) | Cyclodextrin-modified polyamines for delivery of therapeutic molecules | |
| Ramezani et al. | Graphene-based hybrid nanomaterials for biomedical applications | |
| JP2012503603A5 (cg-RX-API-DMAC7.html) | ||
| JP2011528654A5 (cg-RX-API-DMAC7.html) | ||
| WO2007099660A1 (ja) | 核酸内包高分子ミセル複合体 | |
| ES2265291B1 (es) | Nuevos dendrimeros carbosilanos, su preparacion y sus usos. | |
| US11739162B2 (en) | Side chain modified peptoids useful as structure-stabilizing coatings for biomaterials | |
| Munir et al. | Dendrimers and their applications: a review article | |
| Shcharbin et al. | Recent patents in dendrimers for nanomedicine: evolution 2014 | |
| Maly et al. | Highly organized self-assembled dendriplexes based on poly (propylene imine) glycodendrimer and anti-HIV oligodeoxynucleotides | |
| JP2016516079A5 (cg-RX-API-DMAC7.html) | ||
| Yakimova et al. | Polyammonium derivatives of (thia) calix [4] arene: synthesis and interaction with nucleic acids | |
| US20150250892A1 (en) | Biodegradable polymeric buffers | |
| US10010627B2 (en) | Modified polycationic polymers | |
| Kaur et al. | Biopolymeric conjugation with polynucleotides and applications |